A multidisciplinary prehabilitation protocol shows promise in reversing frailty and improving outcomes for patients with ...

Solid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates targeting rare neuromuscular and cardiac diseases, including Duchenne muscular ...

Polymorphic defense is a radically new evolution in cybersecurity, but it has deep roots in military doctrine.

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a malignant inherited cardiac condition, with a higher lethality than long QT syndrome and hypertrophic cardiomyopathy. The annual ...

The Future is Here: Ventricular Assist Devices for the Failing Heart Ana C Alba; Diego H Delgado Disclosures Expert Rev Cardiovasc Ther. 2009;7 (9):1067-1077. Expert Commentary ...

Probably the greater circulating angiotensin II concentrations associated with the ACE gene deletion polymorphism [40] could influence left ventricular remodeling through either direct myocardial ...

A 4D imaging, MRI-guided approach to lead placement for cardiac resynchronization therapy was not only feasible and safe but demonstrated significant improvement in left ventricular function vs ...

Hospitals with a higher volume of percutaneous microaxial ventricular assist device implantation in the US have fewer deaths among cardiogenic shock patients.

On Nov. 18, the heart failure and transplantation team at Emory University Hospital (EUH) made history, performing the first-ever surgical implantation in the United States of a brand-new type of ...

Ventricular Assist Devices play a key role in heart failure treatment, utilizing cutting-edge technology to improve patient outcomes and cardiac health.

Pulseless ventricular tachycardia is a life threatening heart condition. Learn how to recognize the symptoms and how doctors treat and manage this condition.